retatrutide phase 3 trial results just delivered the first top-line for a triple agonist in obesity β and the findings from TRIUMPH-4 are strikingπ Initial Reta Phase 3 Trials
Description
The starting dose affected side effects but not final outcomes

This support system fosters accountability and encourages long-term adherence to treatment plans

However, if your next scheduled dose is less than 2 days (48 hours) away , you should skip the missed dose entirely

There is evidence for expression of the GIPR by alpha-, beta-, and delta-cells in pancreatic islets 5658 , white and brown adipose tissue 59,60 , and various regions of the CNS 54,61,62
Not because theyve sworn them off
